Service Platform
Related Services and Solutions
We look forward to working with you and providing you with excellent service.
DP Production Base — Rayhua Zhongshan
The RuHua Zhongshan formulation factory, owned by Sandoz (China), is a formulation production base established by the Sandoz Group, a subsidiary of Novartis, in China. It joined Jiuzhou Pharmaceutical on March 31, 2023, and has established a comprehensive quality management system. The factory possesses advanced capabilities in solid dosage forms, ointments (gels), and oral liquids, and has extensive experience in product process improvement, technology transfer, and reliable supply capabilities.
Area：50,000 square meters. The factory has completed the construction of solid dosage form, ointment (gel), and oral liquid workshops that comply with Chinese GMP standards, and is planning to build an anti-tumor formulation workshop.
Quality Management System：Based on GMP standards from NMPA, ICH, FDA, and the European Union, a comprehensive quality management system has been established, covering the entire lifecycle of the product. Adhering to a culture of continuous improvement, it ensures the efficiency and compliance of production operations.
Management Team：The core management team comes from international pharmaceutical companies, with rich experience in technology transfer, product project management, and quality management. They have extensive practical experience in national drug procurement supply.
Business Scope：It builds a one-stop service from preclinical pharmaceutical research to commercial production of formulations. Introduced projects cover the research and development of innovative drugs, improved new drugs, high-end generic drugs, generic drug consistency evaluation CDMO, as well as technical consulting and registration applications.
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039
E-mail: bd.cdmo@jiuzhoupharma.com
